Catalys Pacific, LLC — Q1 2026 13F-HR

← Catalys Pacific, LLC

Q1 2026 · 13F-HR

Catalys Pacific, LLCholdings as filed

Filed 2026-05-14 · accession 0001104659-26-060911

$230.7M

Reported value

Positions

2026-03-31

Period end

View analyzed profile →PRO

The Brief · Catalys Pacific, LLC · Q1 2026

AI · grounded in 13F

Catalys Pacific, LLC increased its position in Phathom Pharmaceuticals, Inc. PHAT by 4.54%. The fund added one new position to its portfolio. Total assets under management stand at $230.71 million across two positions.

Holdings as filed

CUSIP	Ticker	Issuer	Value	% port.	Shares	Class	Voting
603170101	MLYS	Mineralys Therapeutics, Inc.	$214.1M	92.8%	7,903,838	Common	SOLE
71722W107	PHAT	Phathom Pharmaceuticals, Inc.	$16.6M	7.19%	1,493,854	Common	SOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.